XBIO/ 09/16/2026 · 7:30 AM Xenetic and Santersus Combine to Build a Nasdaq Company Targeting Neutrophil Extracellular Traps NucleoCapture and DNase will target NETs in sepsis, lupus, transplant and lymphoma.
